Intermuscular adipose tissue is associated with monocyte chemoattractant protein-1, independent of visceral adipose tissue

Clinical Biochemistry

Volumn 49, Issue 6, 2016, Pages 439-443

  Haam, Ji Hee ^a   Kim, Young Sang ^a   Koo, Hyung Suk ^b   Haam, Juhee ^c   Seo, Nam Kyoung ^a   Kim, Hyung Yuk ^a   Park, Kyung Chae ^a   Park, Kye Seon ^a   Kim, Moon Jong ^a  

^a CHA University   (South Korea)

^b Dongguk University Bundang Oriental Hospital   (South Korea)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Adiponectin; Intermuscular adipose tissue; Leptin; MCP 1; Obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INSULIN; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; ASSESSMENT OF HUMANS; BLOOD SAMPLING; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION COEFFICIENT; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INTERMUSCULAR ADIPOSE TISSUE; INTRAABDOMINAL FAT; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE TISSUE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERUM; SUBCUTANEOUS FAT; METABOLISM; MUSCLE; OBESITY;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; CHEMOKINE CCL2; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LEPTIN; MIDDLE AGED; MUSCLES; OBESITY;

EID: 84951763351     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.12.003     Document Type: Article

References (44)

1. Britton K.A., Fox C.S. Ectopic fat depots and cardiovascular disease. Circulation 2011, 124:e837-e841.
2. Ding J., Hsu F.C., Harris T.B., Liu Y., Kritchevsky S.B., Szklo M., et al. The association of pericardial fat with incident coronary heart disease: the multi-ethnic study of atherosclerosis (mesa). Am. J. Clin. Nutr. 2009, 90:499-504.
3. Krssak M., Falk Petersen K., Dresner A., DiPietro L., Vogel S.M., Rothman D.L., et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 h NMR spectroscopy study. Diabetologia 1999, 42:113-116.
4. Lehman S.J., Massaro J.M., Schlett C.L., O'Donnell C.J., Hoffmann U., Fox C.S. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham heart study. Atherosclerosis 2010, 210:656-661.
5. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
6. Inadera H. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int. J. Med. Sci. 2008, 5:248-262.
7. Van Gaal L.F., Mertens I.L., De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444:875-880.
8. Kim C.S., Park H.S., Kawada T., Kim J.H., Lim D., Hubbard N.E., et al. Circulating levels of mcp-1 and il-8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes. 2006, 30:1347-1355.
9. Piemonti L., Calori G., Mercalli A., Lattuada G., Monti P., Garancini M.P., et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 2003, 26:2883-2889.
10. Cai K., Qi D., Hou X., Wang O., Chen J., Deng B., et al. Mcp-1 upregulates amylin expression in murine pancreatic beta cells through erk/jnk-ap1 and nf-kappab related signaling pathways independent of ccr2. PLoS One 2011, 6.
11. Ashida N., Arai H., Yamasaki M., Kita T. Distinct signaling pathways for mcp-1-dependent integrin activation and chemotaxis. J. Biol. Chem. 2001, 276:16555-16560.
12. Piya M.K., McTernan P.G., Kumar S. Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. J. Endocrinol. 2013, 216:T1-T15.
13. Soodini G.R. Adiponectin and leptin in relation to insulin sensitivity. Metab. Syndr. Relat. Disord. 2004, 2:114-123.
14. Zuo H., Shi Z., Yuan B., Dai Y., Wu G., Hussain A. Association between serum leptin concentrations and insulin resistance: a population-based study from China. PLoS One 2013, 8.
15. Lee E.S., Lee D.H., Kim S.Y., Kim J.Y., Kim W.S., Lee H.J., Choi W., Kim P.S., Kim H.G., Kim Y.S. Relationship between blood leptin and non alcoholic fatty liver in obese male adolescent. Korean Journal of Medicine 2001, 61.
16. Guzik T.J., Mangalat D., Korbut R. Adipocytokines-novel link between inflammation and vascular function?. J. Physiol. Pharmacol. 2006, 57:505-528.
17. Yamauchi T., Iwabu M., Okada-Iwabu M., Kadowaki T. Adiponectin receptors: a review of their structure, function and how they work. Best Pract. Res. Clin. Endocrinol. Metab. 2014, 28:15-23.
18. Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46:459-469.
19. Bruun J.M., Lihn A.S., Pedersen S.B., Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (at): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 2005, 90:2282-2289.
20. Malavazos A.E., Cereda E., Morricone L., Coman C., Corsi M.M., Ambrosi B. Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity. Eur. J. Endocrinol./Eur. Fed. of Endocr. Soc. 2005, 153:871-877.
21. Yim J.E., Heshka S., Albu J., Heymsfield S., Kuznia P., Harris T., et al. Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int. J. Obes. 2007, 31:1400-1405.
22. Durheim M.T., Slentz C.A., Bateman L.A., Mabe S.K., Kraus W.E. Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and visceral adiposity. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E407-E412.
23. Therkelsen K.E., Pedley A., Speliotes E.K., Massaro J.M., Murabito J., Hoffmann U., et al. Intramuscular fat and associations with metabolic risk factors in the Framingham heart study. Arterioscler. Thromb. Vasc. Biol. 2013, 33:863-870.
24. Committee S. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment 2000, 11-12. International Diabetes Institute, Melbourne.
25. Kim M.K., Lee W.Y., Kang J.H., Kang J.H., Kim B.T., Kim S.M., et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol. Metab. 2014, 29:405-409.
26. Kim S., Cho B., Lee H., Choi K., Hwang S.S., Kim D., et al. Distribution of abdominal visceral and subcutaneous adipose tissue and metabolic syndrome in a Korean population. Diabetes Care 2011, 34:504-506.
27. Park Y.S., Kwon H.T., Hwang S.S., Choi S.H., Cho Y.M., Lee J., et al. Impact of visceral adiposity measured by abdominal computed tomography on pulmonary function. J. Korean Med. Sci. 2011, 26:771-777.
28. Patsouris D., Li P.P., Thapar D., Chapman J., Olefsky J.M., Neels J.G. Ablation of cd11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 2008, 8:301-309.
29. Di Gregorio G.B., Yao-Borengasser A., Rasouli N., Varma V., Lu T., Miles L.M., et al. Expression of cd68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005, 54:2305-2313.
30. Hou X., Wang O., Li Z., Mou H., Chen J., Deng B., et al. Upregulation of pancreatic derived factor (fam3b) expression in pancreatic beta-cells by mcp-1 (ccl2). Mol. Cell. Endocrinol. 2011, 343:18-24.
31. Curat C.A., Wegner V., Sengenes C., Miranville A., Tonus C., Busse R., et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49:744-747.
32. Pou K.M., Massaro J.M., Hoffmann U., Vasan R.S., Maurovich-Horvat P., Larson M.G., et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham heart study. Circulation 2007, 116:1234-1241.
33. Britton K.A., Fox C.S. Perivascular adipose tissue and vascular disease. J. Clin. Lipidol. 2011, 6:79-91.
34. Chatterjee T.K., Stoll L.L., Denning G.M., Harrelson A., Blomkalns A.L., Idelman G., et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ. Res. 2009, 104:541-549.
35. Goodpaster B.H., Thaete F.L., Kelley D.E. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am. J. Clin. Nutr. 2000, 71:885-892.
36. Goodpaster B.H., Krishnaswami S., Resnick H., Kelley D.E., Haggerty C., Harris T.B., et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003, 26:372-379.
37. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11:85-97.
38. Zimmet P.Z., Collins V.R., de Courten M.P., Hodge A.M., Collier G.R., Dowse G.K., et al. Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius. Mauritius NCD Study Group. Int. J. Obes. Relat. Metab. Disord. 1998, 22:171-177.
39. Yadav A., Kataria M.A., Saini V., Yadav A. Role of leptin and adiponectin in insulin resistance. Clin. Chim. Acta 2013, 417:80-884.
40. Minocci A., Savia G., Lucantoni R., Berselli M.E., Tagliaferri M., Calo G., et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int. J. Obes. Relat. Metab. Disord. 2000, 24:1139-1144.
41. Park K.G., Park K.S., Kim M.J., Kim H.S., Suh Y.S., Ahn J.D., et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res. Clin. Pract. 2004, 63:135-142.
42. Van Harmelen V., Reynisdottir S., Eriksson P., Thorne A., Hoffstedt J., Lonnqvist F., et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998, 47:913-917.
43. Carbo N., Ribas V., Busquets S., Alvarez B., Lopez-Soriano F.J., Argiles J.M. Short-term effects of leptin on skeletal muscle protein metabolism in the rat. J. Nutr. Biochem. 2000, 11:431-435.
44. Kohara K., Ochi M., Tabara Y., Nagai T., Igase M., Miki T. Leptin in sarcopenic visceral obesity: possible link between adipocytes and myocytes. PLoS One 2011, 6.